Med-Scribe Transcription Service is categorized under Business Services (Unclassified) in Lufkin, TX and active since 1997.
Med-Scribe Transcription Service was established in 1997, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact M L Adams at the company’s single location by writing to 904 Renfro Drive, Lufkin, Texas TX 75901 or by phoning (936) 632-4217. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Med-Scribe Transcription Service |
| Contact Person: | M L Adams |
| Address: | 904 Renfro Drive, Lufkin, Texas 75901 |
| Phone Number: | (936) 632-4217 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Med-Scribe Transcription Service was started in 1997 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact M L Adams for inquiries that concern Med-Scribe Transcription Service by calling the company number (936) 632-4217, as your correspondence is most welcome. Additionally, the physical location of the single location of Med-Scribe Transcription Service can be found at the coordinates 31.329564,-94.694557 as well as the street address 904 Renfro Drive in Lufkin, Texas 75901.
For its online presence, you may visit Med-Scribe Transcription Service’s website at and engage with its social media outlets through on Twitter and on Facebook.